Subsequently, XAF1 knockdown group showed a distinct increase in tumor growth rate compared to the control group, suggesting that XAF1 knockdown promotes neuroblastoma tumor growth in vivo (Figure 5B and 5C). The gene discussed is XAF1; the disease is neuroblastoma.